The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characteristics of metastatic renal cell carcinoma (mRCC) patients treated with delayed targeted therapy: results from the International mRCC Consortium (IMDC).
 
Haoran Li
No Relationships to Disclose
 
Toni K. Choueiri
Honoraria - NCCN; UpToDate
Consulting or Advisory Role - AVEO; Bayer; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); TRACON Pharma (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Pfizer
 
Connor Wells
No Relationships to Disclose
 
Neeraj Agarwal
Research Funding - amgen (Inst); Bayer (Inst); BN ImmunoTherapeutics (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); ImClone Systems (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Takeda (Inst)
Other Relationship - Exelixis; Medivation; Takeda
 
Frede Donskov
Research Funding - GlaxoSmithKline; Novartis; Pfizer
 
Jae-Lyun Lee
Honoraria - Pfizer
Consulting or Advisory Role - Astellas Pharma
Research Funding - Pfizer
 
Reuben James Broom
No Relationships to Disclose
 
Takeshi Yuasa
No Relationships to Disclose
 
Brian I. Rini
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Immatics (Inst); Millennium (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Sumanta Kumar Pal
Honoraria - Medivation; Novartis
Consulting or Advisory Role - Aveo; Myriad Pharmaceuticals; Novartis; Pfizer
Research Funding - Medivation
 
Lori Wood
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Novartis
Other Relationship - Janssen Oncology; Pfizer
 
D. Scott Ernst
No Relationships to Disclose
 
Christian K. Kollmannsberger
Honoraria - GlaxoSmithKline; Novartis; Pfizer
Consulting or Advisory Role - GlaxoSmithKline; Novartis; Pfizer
Research Funding - GlaxoSmithKline; Novartis; Pfizer
 
Ulka N. Vaishampayan
Honoraria - Astellas Pharma; Bayer; Janssen; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; Novartis; Pfizer
Speakers' Bureau - Astellas Pharma; Bayer; Janssen; Novartis; Pfizer
Research Funding - Astellas Pharma; Exelixis; Novartis
 
Sun Young Rha
Consulting or Advisory Role - GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bayer; Novartis
 
Georg A. Bjarnason
Honoraria - Pfizer
Consulting or Advisory Role - Pfizer
Research Funding - Pfizer
 
Jennifer J. Knox
Consulting or Advisory Role - AVEO
Research Funding - Pfizer
 
Sadia Saleem
No Relationships to Disclose
 
Benoit Beuselinck
No Relationships to Disclose
 
Daniel Yick Chin Heng
Consulting or Advisory Role - Bayer/Onyx; Novartis; Pfizer